MUSTANG BIO, INC. Deferred Tax Assets, Operating Loss Carryforwards
MUSTANG BIO, INC. (MBIO) had Deferred Tax Assets, Operating Loss Carryforwards of $103.70 million as of 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-19
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $103.70M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $95.13M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $84.65M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $75.01M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $103.70M 10-K · filed 2026-03-19 |
| 2024-12-31 | $95.13M 10-K · filed 2026-03-19 |
| 2023-12-31 | $84.65M 10-K · filed 2025-03-28 |
| 2022-12-31 | $75.01M 10-K · filed 2024-03-11 |
| 2021-12-31 | $66.88M 10-K · filed 2023-03-30 |
| 2020-12-31 | $45.09M 10-K · filed 2022-03-23 |
| 2019-12-31 | $27.45M 10-K · filed 2021-03-24 |
| 2018-12-31 | $14.30M 10-K · filed 2020-03-16 |
| 2017-12-31 | $7.24M 10-K · filed 2019-03-18 |
| 2016-12-31 | $3.31M 10-K · filed 2018-03-29 |
| 2015-12-31 | $893.00K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |